Q/C Technologies, Inc. Available-for-sale Securities, Gross Unrealized Gain
Q/C Technologies, Inc. (QCLS) reported Available-for-sale Securities, Gross Unrealized Gain of $1.01 thousand for the 6-month period ending 2017-06-30, per its 10-Q/A filed 2018-07-13.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2018-07-13
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2017-06-30 was $853.00.
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2017-03-31 was $156.00, a 94.82% decline year-over-year.
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2016-09-30 was -$1.37K.
- Q/C Technologies, Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2016-06-30 was -$1.62K, a 202.46% decline year-over-year.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 6 month | Available-for-sale Securities, Gross Unrealized Gain 9 month |
|---|---|---|---|
| 2017-06-30 | $853.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-07-13 | $1.01K 10-Q/A · filed 2018-07-13 | |
| 2017-03-31 | $156.00 10-Q · filed 2017-05-15 | ||
| 2016-09-30 | -$1.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$2.99K derived: sum of 2 quarters · filed 2016-11-14 | $20.00 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$1.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.39K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $3.01K 10-Q · filed 2016-05-12 | ||
| 2015-09-30 | -$1.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $308.00 derived: sum of 2 quarters · filed 2015-11-13 | $10.06K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $1.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-18 | $11.34K 10-Q · filed 2015-08-18 | |
| 2015-03-31 | $9.76K 10-Q · filed 2015-05-14 | ||
| 2014-09-30 | $2.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $2.79K derived: sum of 2 quarters · filed 2014-11-13 | $3.32K 10-Q · filed 2014-11-13 |
| 2014-06-30 | -$194.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $340.00 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $534.00 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |